IP Library Granted Patent US 11,684,049
Granted Patent B2
US 11,684,049 · App. 16/915,859 · Granted Jun 27, 2023

Recombinant constructs and transgenic fluorescent ornamental fish therefrom

Inventors: Alan Blake (Austin, TX); Richard Crockett (Wilton, CT); Jeffrey Essner (Ames, IA); Perry Hackett (Saint Paul, MN); Aidas Nasevicius (Tampa, FL)
Assignee: GloFish LLC
A01K67/0275A01K67/027C07K14/43595C12N15/8509G06Q99/00A01K2217/05A01K2217/052A01K2217/206A01K2227/40A01K2267/0393C12N2830/008
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,684,049
App. No.
16/915,859
Granted
Jun 27, 2023
Kind
B2
Abstract

The present invention relates to the method and use of reef coral fluorescent proteins in making transgenic red, green and yellow fluorescent zebrafish. Preferably, such fluorescent zebrafish are fertile and used to establish a population of transgenic zebrafish and to provide to the ornamental fish industry for the purpose of marketing. Thus, new varieties of ornamental fish of different fluorescence colors from a novel source are developed.

Claims (29)

1. A method of making a transgenic fluorescent fish progeny comprising the steps:

(a) selecting a first transgenic fluorescent fish comprising a first transgene encoding a first fluorescent protein, and a second transgene encoding a second fluorescent protein; and

(b) breeding the first transgenic fish with a second fish to make a transgenic fluorescent fish progeny, wherein the transgenic fluorescent fish progeny comprises in its genome:

(i) the first transgene encoding the first fluorescent protein, wherein the first transgene is under the control of a muscle specific promoter, and

(ii) the second transgene encoding the second fluorescent protein, wherein the second transgene is under the control of a ubiquitous fish promoter;

wherein the first and second transgene encode different fluorescent proteins, and wherein the transgenic fluorescent fish progeny visibly expresses a fluorescent color different from the color encoded by the first transgene and the second transgene, and wherein the transgenic fluorescent fish progeny exhibits a strong visible fluorescence over 75% to 100% of the body of said fish, optionally excluding fins and eyes, wherein at least one of the first and second transgene comprises a nucleic acid sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, and SEQ ID NO:5.

2. The method of claim 1 , wherein the first and second transgenes are both chromosomally integrated and each of said first and second transgenes are inserted into said transgenic fluorescent fish progeny independently from one another.

3. The method of claim 1 , wherein the first transgene encodes a red fluorescent protein.

4. The method of claim 1 , wherein the second transgene encodes a yellow fluorescent protein.

5. The method of claim 1 , wherein the first transgene encodes a red fluorescent protein and the second transgene encodes a yellow fluorescent protein.

6. The method of claim 1 , wherein the transgenic fluorescent fish progeny genome comprises at least two nucleic acid sequences selected from the group consisting of SEQ ID NO: 1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, and SEQ ID NO:5.

7. A method of making a transgenic fluorescent fish progeny comprising the steps:

(a) selecting a first transgenic fluorescent fish comprising a first transgene encoding a first fluorescent protein, and a second transgene encoding a second fluorescent protein; and

(b) breeding the first transgenic fish with a second fish to make a transgenic fluorescent fish progeny, wherein the transgenic fluorescent fish progeny comprises in its genome:

(i) the first transgene encoding the first fluorescent protein, wherein the first transgene is under the control of a muscle specific promoter, and

(ii) the second transgene encoding the second fluorescent protein, wherein the second transgene is under the control of a muscle specific promoter;

wherein the first and second transgene encode different fluorescent proteins, and wherein the transgenic fluorescent fish progeny visibly expresses a fluorescent color different from the color encoded by the first and second transgene, and wherein the transgenic fluorescent fish progeny exhibits a strong visible fluorescence over 75% to 100% of the body of said fish, optionally excluding fins and eyes, wherein at least one of the first transgene and the second transgene comprises a nucleic acid sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO:3, and SEQ ID NO:4.

8. The method of claim 7 , wherein the first transgene encodes a red fluorescent protein.

9. The method of claim 7 , wherein the second transgene encodes a yellow fluorescent protein.

10. The method of claim 7 , wherein the first transgene encodes a red fluorescent protein and the second transgene encodes a yellow fluorescent protein.

11. The method of claim 7 , wherein the muscle specific promoter of the first transgene and the second transgene are each selected from the group consisting of fast skeletal muscle specific myosin light chain, muscle creatine kinase, MyoD, myogenin, desmin, muscle enolase-3, β-sarkoglycan, dystrophin, serum response factor, a-tropomyosin, myosin heavy chain, mitochondrial creatine kinase 2, Ca2+ transporting ATPase (fast twitch 1), skeletal troponin T1 (slow), tropomodulin 4, four and a half LIM domains 1, fast-type nyosin binding protein C, calsequestrin 1, fast muscle troponin C2, phosphorylase kinase alpha 1, and skeletal Troponin I (fast 2).

12. The method of claim 11 , wherein the muscle specific promoter of the first transgene and the second transgene are the same.

13. The method of claim 7 , wherein the transgenic fluorescent fish progeny genome comprises at least two nucleic acid sequences selected from the group consisting of SEQ ID NO: 1, SEQ ID NO:3, and SEQ ID NO:4.

14. The method of claim 1 , wherein the second fish is a transgenic fish.

15. The method of claim 1 , wherein the transgenic fluorescent fish progeny genome comprises at least two nucleic acid sequences selected from the group consisting of SEQ ID NO: 1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:4, and SEQ ID NO:5.

16. The method of claim 7 , wherein the second fish is a transgenic fish.

17. The method of claim 7 , wherein the transgenic fluorescent fish progeny genome comprises at least two nucleic acid sequences selected from the group consisting of SEQ ID NO: 1, SEQ ID NO:3, and SEQ ID NO:4.

18. The method of claim 1 , wherein the transgenic fluorescent fish progeny further comprises in its genome a third transgene encoding a third fluorescent protein, wherein the third transgene is under the control of a ubiquitous fish promoter.

19. The method of claim 7 , wherein the transgenic fluorescent fish progeny further comprises in its genome a third transgene encoding a third fluorescent protein, wherein the third transgene is under the control of a muscle specific promoter.

Assignments (1)
SECURITY INTEREST Recorded Jun 24, 2021
From: GLOFISH LLC; SPECTRUM BRANDS, INC.; UNITED INDUSTRIES CORPORATION
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 056660/0484 →